# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 61-70 of 573 results.
Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
Status: Not yet recruiting
Last Changed: Nov 13, 2019
First Received: Nov 13, 2019
Disease(s): Lymphoma, B-Cell
Intervention(s): Venetoclax, RiTUXimab Injection, Rituximab SC, Gemcitabine, Dexamethasone, Cisplatin
Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Jan 26, 2017
First Received: Jun 17, 2015
Disease(s): Diffuse Large B Cell Lymphoma, Neutropenia, Febrile
Locations: Ajou Universtiy School of Medicine, Suwon, Kyeonggi, Korea, Republic of
Soon Chun Yang University Hospital Bucheon, Bucheon, Korea, Republic of
Busan Paik Hospital, Busan, Korea, Republic of
Chungbuk National University Hospital, Cheongju, Korea, Republic of
Keimyung Univerisity Dongsan Medical Center, Daegu, Korea, Republic of
... and 20 other locations.
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Status: Recruiting
Last Changed: Mar 25, 2019
First Received: Jul 02, 2017
Disease(s): Mature B-cell Non-Hodgkin Lymphoma
Intervention(s): Rituximab window, Additional doses of Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin hydrochloride, Vindesine Sulfate, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Locations: Univ.Klinik für Kinder- und Jugendheilkunde Graz, Klin. Abteilung für pädiatrische Hämato-Onkologie, Graz, Austria
Univ.Klinik für Kinder- und Jugendheilkunde Innsbruck, Universitätsklinik für Pädiatrie I, Innsbruck, Austria
Klinikum Klagenfurt am Wörthersee, Abteilung für Kinder- und Jugendheilkunde, Klagenfurt, Austria
LKH Leoben, Abteilung für Kinder- und Jugendheilkunde, Leoben, Austria
Kepler Universitätsklinikum, Med Campus IV / Onkologie, Linz, Austria
... and 87 other locations.
Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Mar 08, 2018
Disease(s): Lymphoma, B-Cell
Intervention(s): Roflumilast
Locations: Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States
ctDNA and Metabolites in CSF as Early Biomarkers of Secondary CNS Involvement in Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Oct 04, 2019
First Received: Oct 02, 2019
Disease(s): Diffuse Large B Cell Lymphoma, Central Nervous System Metastasis
Locations: Herlev Hopital, Herlev, Capital Region, Denmark
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Jan 03, 2019
First Received: May 10, 2016
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Rituximab, Gemcitabine, Oxaliplatin, Cyclophosphamide, Epirubicin Injectable Product, Vindesine, Prednisone
Locations: Tongji Medical College of HUST, Wuhan, Hubei, China
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), NanJing, Jiangsu, China
QiLu Hospital of Shandong University, Jinan, Shandong, China
Shandong Province Hospital, Jinan, Shandong, China
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
... and 2 other locations.
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Recruiting
Last Changed: Nov 21, 2019
First Received: Nov 09, 2015
Disease(s): Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Intervention(s): Lenalidomide, Obinutuzumab, Polatuzumab Vedotin, Rituximab
Locations: Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital, Marietta, Georgia, United States
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
University of Missouri/Ellis Fischel, Columbia, Missouri, United States
Washington University; Wash Uni. Sch. Of Med, Saint Louis, Missouri, United States
NYU School of Medicine, New York, New York, United States
... and 25 other locations.
DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma
Status: Recruiting
Last Changed: Feb 12, 2019
First Received: Feb 12, 2019
Disease(s): Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma
Intervention(s): Rituximab, Etoposide, Vincristine, Doxorubicin, Dexamethasone, Cyclophosphamide, Lenalidomide, Cisplatin, Cytarabine
Locations: Hunan Cancer Hospital, Changsha, Hunan, China
the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
the First Affiliated Hospital of Jilin University, Changchun, Jilin, China
the Second Hospital of Dalian Medical University, Dalian, Liaoning, China
Qingdao Central Hospital, Qingdao, Shandong, China
... and 2 other locations.
Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
Status: Recruiting
Last Changed: Jul 04, 2019
First Received: Mar 27, 2019
Disease(s): Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma
Intervention(s): Selicrelumab, Atezolizumab
Locations: APHP - Hôpital Henri Mondor, Créteil, France
CHU de Montpellier, Montpellier, France
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud, Pierre-Bénite, France
CHU de Rennes - Hôpital Pontchaillou, Rennes, France
Institut Gustave Roussy, Villejuif, France
... and 1 other locations.
Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
Status: Recruiting
Last Changed: Aug 09, 2019
First Received: May 06, 2019
Disease(s): Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma
Intervention(s): Abexinostat, Ibrutinib
Locations: Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memoral Sloan Kettering Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Commack, Commack, New York, United States
Memorial Sloan Kettering Westchester, Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
... and 2 other locations.